Opener:

 

For the past year, an assumption — sometimes explicit, often tacit — has informed almost all our thinking about the pandemic: At some point, it will be over, and then we’ll go “back to normal.”

 

This premise is almost certainly wrong. SARS-CoV-2, protean and elusive as it is, may become our permanent enemy, like the flu but worse. And even if it peters out eventually, our lives and routines will by then have changed irreversibly. Going “back” won’t be an option; the only way is forward. But to what exactly?

 

Conclusion:

 

But we must also be realistic. Resilience demands that we include this new scenario into our planning. The good news is that we keep getting better at responding. In each lockdown, for example, we damage the economy less than in the previous one. And we may achieve scientific breakthroughs that will eventually make life better. Our Brave New World needn’t be dystopian. But it won’t look anything like the old world.

 

 

 

 

 

 

The article has gotten some attention over the last few days. And, if apabetalone "comes through for all of us" in the upcoming trials, one has to again wonder - like some previous posters have - what kind of $$$ numbers we could potentially be looking at? Would apabetalone be used short term, during the peak season, or year round? So many questions....